Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors
- 1Department of Life Sciences, School of Life and Health Sciences, European University Cyprus, Nicosia 1516, Cyprus
- 2Cancer Genetics, Genomics and Systems Biology Laboratory, Basic and Translational Cancer Research Center (BTCRC), Nicosia 1516, Cyprus
- 3Division of Pharmacology and Toxicology, Dell Paediatric Research Institute, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA
Abstract
The apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) family comprises ten cytidine deaminases implicated in cancer mutagenesis, yet their broader biological significance remains incompletely understood. We performed an integrated pan-cancer analysis of all ten APOBEC family members across 9653 tumors from 33 cancer types in The Cancer Genome Atlas (TCGA), combining mutational signatures, sequence-context enrichment, transcriptomics, immune microenvironment profiling, stemness, clinical outcomes, and somatic mutation analyses. APOBEC enrichment was detected in 17.6% of tumors and exhibited marked cancer-type specificity, with the highest prevalence in bladder, cervical, and head and neck carcinomas. Associations between binary APOBEC enrichment and advanced stage or poorer survival were largely attenuated after adjustment for cancer type. In contrast, exploratory analysis of continuous APOBEC burden revealed a nonlinear association with mortality, although this relationship showed substantial cancer-specific heterogeneity and requires independent validation. Coding mutations in APOBEC genes were rare, showed no evidence of positive selection, and were not consistently associated with altered expression, indicating that dysregulated expression rather than genetic alteration is the predominant mode of APOBEC involvement in cancer. Most APOBEC3 genes were upregulated in tumors, particularly APOBEC3B, whereas APOBEC2 was broadly downregulated. APOBEC3A, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H were consistently associated with immune infiltration, immune-checkpoint expression, and inflammatory immune-cell populations across multiple analytical platforms. After adjustment for tumor purity and ploidy, most APOBEC family members showed negative associations with stemness, whereas APOBEC3B displayed predominantly positive associations. Collectively, these findings reveal substantial heterogeneity within the APOBEC family and support evaluating individual APOBEC members, particularly APOBEC3A and APOBEC3B, as distinct cancer biomarkers.
Related
- Epidemiology, risk factors and clinical outcome of community-acquired pneumonia in severely immunosuppressed patients: a comprehensive analysis from the multinational, prospective CAPNETZ Cohort
- Medico-legal integration of molnupiravir rapid deployment during the COVID-19 pandemic: Emergency use authorization, clinical evidence, and risk of viral mutagenesis
- Perspectives of consumer involvement in pre-clinical musculoskeletal research: a cross-sectional survey of consumers and community members.
- Bioelectric Design of Charged Hydrogels for Stem Cell Fate Control: Fixed-Charge Density, the Ionic Microenvironment, and the Path from Donnan Physics to Regenerative Medicine — A Comprehensive Review
- Therapies for Alcohol Use Disorder in Alcohol-associated Hepatitis Clinical Trials: Integrated Trial Design with a Composite Clinical Outcome as the Primary Endpoint
BibTeX
@article{ghniem2026pancancer,
title = {{Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors}},
author = {Sairos Ghniem and Ilias Georgakopoulos-Soares and Apostolos Zaravinos},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27198864},
url = {https://www.mdpi.com/1422-0067/27/19/8864},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Pan-Cancer APOBEC Mutagenesis, Immune Microenvironment, and Clinical Outcome: A Comprehensive Multi-Omics Analysis of All Ten Family Members Across 9653 TCGA Tumors
AU - Sairos Ghniem
AU - Ilias Georgakopoulos-Soares
AU - Apostolos Zaravinos
PY - 2026
DA - 2026/10/05
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27198864
UR - https://www.mdpi.com/1422-0067/27/19/8864
AB - The apolipoprotein B mRNA-editing catalytic polypeptide-like (APOBEC) family comprises ten cytidine deaminases implicated in cancer mutagenesis, yet their broader biological significance remains incompletely understood. We performed an integrated pan-cancer analysis of all ten APOBEC family members across 9653 tumors from 33 cancer types in The Cancer Genome Atlas (TCGA), combining mutational signatures, sequence-context enrichment, transcriptomics, immune microenvironment profiling, stemness, clinical outcomes, and somatic mutation analyses. APOBEC enrichment was detected in 17.6% of tumors and exhibited marked cancer-type specificity, with the highest prevalence in bladder, cervical, and head and neck carcinomas. Associations between binary APOBEC enrichment and advanced stage or poorer survival were largely attenuated after adjustment for cancer type. In contrast, exploratory analysis of continuous APOBEC burden revealed a nonlinear association with mortality, although this relationship showed substantial cancer-specific heterogeneity and requires independent validation. Coding mutations in APOBEC genes were rare, showed no evidence of positive selection, and were not consistently associated with altered expression, indicating that dysregulated expression rather than genetic alteration is the predominant mode of APOBEC involvement in cancer. Most APOBEC3 genes were upregulated in tumors, particularly APOBEC3B, whereas APOBEC2 was broadly downregulated. APOBEC3A, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H were consistently associated with immune infiltration, immune-checkpoint expression, and inflammatory immune-cell populations across multiple analytical platforms. After adjustment for tumor purity and ploidy, most APOBEC family members showed negative associations with stemness, whereas APOBEC3B displayed predominantly positive associations. Collectively, these findings reveal substantial heterogeneity within the APOBEC family and support evaluating individual APOBEC members, particularly APOBEC3A and APOBEC3B, as distinct cancer biomarkers.
SN - 1422-0067
ER -